Background: Accounting for patients' perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to adapt and pilot this questionnaire for international comparison of cancer patients experience and satisfaction with care in six European countries. Method: The Consumer Quality Index was translated into the local language at the participating pilot sites using cross-translation. A minimum of 100 patients per site were surveyed through convenience sampling. Data from seven pilot sites in six countries was collected through an online and paper-based survey. Internal consistency was tested by calculating Cronbach's alpha and validity by means of cognitive interviews. Demographic factors were compared as possible influencing factors. Results: A total of 698 patients from six European countries filled the questionnaire. Cronbach's alpha was good or satisfactory in 8 out of 10 categories. Patient satisfaction significantly differed between the countries. We observed no difference in patient satisfaction for age, gender, education, and tumor type, but satisfaction was significantly higher in patients with a higher level of activation. Conclusion: This European Cancer Consumer Quality Index(ECCQI) showed promising scores on internal consistency (reliability) and a good internal validity. The ECCQI is to our knowledge the first to measure and compare experiences and satisfaction of cancer patients on an international level, it may enable healthcare providers to improve the quality of cancer care.
Anger can be defined as an emotion consisting of feelings of variable intensity, from mild irritation or annoyance to intense fury and rage. Borderline personality disorder (BPD) is characterized by impulsivity and instability of interpersonal relationships, of self-image, and of negative affects. Borderline personality and trait anger are often observed together. The present study examined the extent to which a genetic association explains the covariation between a trait measure of borderline personality and trait anger. To this end, self-report data of 5,457 twins and 1,487 of their siblings registered with the Netherlands Twin Register and the East Flanders Prospective Twin Survey were analyzed using genetic structural equation modeling. A significant phenotypic correlation was observed between the two traits (rP = .52). This correlation was explained by genetic (54%) and by environmental influences (46%). A shared genetic risk factor is thus one of the explanations for the covariation of borderline personality and trait anger.
Creativity is the tendency to generate or recognize ideas, alternatives, or possibilities. Following a study on the genetic contribution to working in a creative profession, based on polygenic score analysis, we report the total heritability of this trait in a large sample of adult twins and their siblings registered with the Netherlands Twin Register. Data from 6755 twins and 1817 siblings were analyzed using genetic structural equation modeling. Working in a creative profession is relatively rare in our sample (2.6% of twins and 3.2% of siblings). Twin correlations (identical 0.68 and fraternal 0.40) commended a model with additive genetic factors (full model estimate 0.56), shared (full model estimate 0.12), and unique environmental factors (full model estimate 0.32). Genetic model fitting resulted in a best-fitting model existing of additive genetic factors and unique environmental factors, resulting in a heritability of 0.70.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.